Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;81(2):318-356.
doi: 10.1016/j.jinf.2020.03.063. Epub 2020 Apr 10.

Prolonged virus shedding even after seroconversion in a patient with COVID-19

Affiliations
Comment

Prolonged virus shedding even after seroconversion in a patient with COVID-19

Wang-Da Liu et al. J Infect. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None to declare.

Figures

Fig. 1
Fig. 1
Profile of viral load and antibody response to SARS-CoV-2 in the case patient. (A)(B)(C) Sequential changes of SARS-CoV-2 viral load in the throat swab, sputum, and throat wash by gargling. The SARS-CoV-2 viral load was determined using the protocol provided by the WHO (https://virologie-ccm.charite.de/en). Plasmids containing partial E, N, and RdRp fragments were used respectively as the standards to calculate the amount of SARS-CoV-2 viral load in the specimens. (D) Antibody responses of the present case. Antibody responses of the present case to viral proteins extracted from SARS-CoV-2 infected Vero-E6 cells were determined by the western blot.

Comment in

Comment on

References

    1. Tang J.W., Tambyah P.A., Hui D.S.C. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China. J Infect. 2020;80(3):350–371. - PMC - PubMed
    1. Xiao D.A.T., Gao D.C., Zhang D.S. Profile of specific antibodies to SARS-CoV-2: the first report. J Infect. 2020 doi: 10.1016/j.jinf.2020.03.012. pii: S0163-4453(20)30138-9[Epub ahead of print] - DOI - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. [Epub ahead of print] - DOI - PMC - PubMed
    1. Yang W., Cao Q., Qin L., Wang X., Cheng Z., Pan A. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020 doi: 10.1016/j.jinf.2020.02.016. pii: S0163-4453(20)30099-2[Epub ahead of print]<. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19). Available at:https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specim...Accessed 7 Mar 2020.